C07D 267/12
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D267/12 (Condensed with carbocyclic rings or ring systems) appears on 345 US grants and 275 published applications in this corpus.
Search patents in C07D- Granted patents
- 345
- Published applications
- 275
- Assignees
- 166
- Inventors
- 977
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 5 | 0 |
| 1985 | 7 | 0 |
| 1986 | 7 | 0 |
| 1987 | 7 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 7 | 0 |
| 1994 | 9 | 0 |
| 1995 | 12 | 0 |
| 1996 | 8 | 0 |
| 1997 | 20 | 0 |
| 1998 | 20 | 0 |
| 1999 | 12 | 0 |
| 2000 | 7 | 0 |
| 2001 | 3 | 1 |
| 2002 | 5 | 4 |
| 2003 | 5 | 4 |
| 2004 | 1 | 8 |
| 2005 | 5 | 7 |
| 2006 | 3 | 13 |
| 2007 | 6 | 8 |
| 2008 | 2 | 18 |
| 2009 | 5 | 9 |
| 2010 | 3 | 17 |
| 2011 | 3 | 5 |
| 2012 | 6 | 4 |
| 2013 | 5 | 6 |
| 2014 | 3 | 9 |
| 2015 | 9 | 9 |
| 2016 | 3 | 12 |
| 2017 | 9 | 11 |
| 2018 | 6 | 13 |
| 2019 | 32 | 28 |
| 2020 | 12 | 17 |
| 2021 | 10 | 15 |
| 2022 | 13 | 9 |
| 2023 | 8 | 25 |
| 2024 | 6 | 5 |
| 2025 | 10 | 13 |
| 2026 | 7 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Benzonitric heterocyclic compound, preparation method therefor and use thereof18 Aug 2026US 12,709,600 B2Shanghai Institute of Pharmaceutical Industry
- Methods and materials for inhibiting NF-kB activity21 Apr 2026US 12,606,528 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- 15-PGDH inhibitor17 Mar 2026US 12,577,217 B2Kyorin Pharmaceutical Co., Ltd.
- Aromatic ring or heteroaromatic ring derivatives, preparation method therefor and use thereof24 Feb 2026US 12,559,449 B2Shanghai Aryl Pharmtech Co., Ltd.
- Methods and compositions for targeting Tregs using CCR8 inhibitors17 Feb 2026US 12,552,753 B2Nanjing Immunophage Biomedical Co., Ltd.
- Slack-activating compounds and their medical use3 Sep 2026US 2026/0258003 A1
- Nicotinamide derivatives for use in treating disorders associated with kcnk13 activity18 Jun 2026US 2026/0167632 A1Cerevance, Inc.
- Treatment methods16 Apr 2026US 2026/0102407 A1
- Covalent, chemogenetic activators for k2p potassium channels and uses thereof9 Apr 2026US 2026/0098008 A1The Regents of the University of California
- Processes and intermediates for preparing mcl1 inhibitors26 Feb 2026US 2026/0055068 A1Gilead Sciences, Inc.
Most cited
By later US patents
- Tricyclic ethers, their preparation and the pharmaceutical compositions containing them138US 4,496,557 AAdir · 1985
- Benzo-fused lactams that promote the release of growth hormone109US 5,206,235 AMerck & Co., Inc. · 1993
- Pyridopyrrolo benzheterocycles97US 4,238,607 AEndo Laboratories, Inc. · 1980
- Pyridopyrrolobenzheterocycles85US 4,183,936 AEndo Laboratories, Inc. · 1980
- Pyridopyrrolobenzheterocycles84US 4,115,577 AEndo Laboratories, Inc. · 1978